Most HIV-1 transmissions occur at mucosae and involve exposure to semen. Semen contains immunomodulatory factors, which inhibit anti-HIV-1 natural killer cell and T cell responses. We demonstrate high concentrations (1:2 dilution) of seminal plasma (SP) inhibit monocyte phagocytosis and anti-HIV-1 Fc-dependent functions of both neutrophils and monocytes. In addition, slightly lower SP concentrations (1:2–1:10 dilutions) inhibit granulocyte phagocytosis and oxidative burst of both monocytes and granulocytes. These observations may have implications for HIV-1 infectivity after mucosal exposure.
Get full access to this article
View all access options for this article.
References
1.
HaynesBF, GilbertPB, McElrathMJ, et al.: Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med, 2012; 366:1275–1286.
2.
MabukaJ, NduatiR, Odem-DavisK, PetersonD, OverbaughJ: HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads. PLoS Pathog, 2012; 8:e1002739.
3.
AlpertMD, HarveyJD, LauerWA, et al.: ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog, 2012; 8:e1002890.
KramskiM, SchorchtA, JohnstonAP, et al.: Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity. J Immunol Methods, 2012; 384:51–61.
6.
DoncelGF, AndersonS, ZalenskayaI: Role of semen in modulating the female genital tract microenvironment—implications for HIV transmission. Am J Reprod Immunol, 2014; 71:564–574.
7.
SharkeyDJ, TremellenKP, JasperMJ, Gemzell-DanielssonK, RobertsonSA: Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol, 2012; 188:2445–2454.
8.
BinksS, PockleyAG: Modulation of leukocyte phagocytic and oxidative burst responses by human seminal plasma. Immunol Invest, 1999; 28:353–364.
9.
SelvaKJ, KentSJ, ParsonsMS: Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma. AIDS, 2017; 31:333–342.
10.
JamesK, HarveyJ, BradburyAW, HargreaveTB, CullenRT: The effect of seminal plasma on macrophage function—A possible contributory factor in sexually transmitted disease. AIDS Res, 1983; 1:45–57.
11.
BarouchDH, StephensonKE, BorducchiEN, et al.: Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell, 2013; 155:531–539.
12.
VeilletteM, CoutuM, RichardJ, et al.: The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. J Virol, 2015; 89:545–551.
13.
KimKA, YolamanovaM, ZirafiO, et al.: Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology, 2010; 7:55.
14.
CauciS, GuaschinoS, De AloysioD, et al.: Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod, 2003; 9:53–58.
15.
HillJA, AndersonDJ: Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am J Obstet Gynecol, 1992; 166:720–726.
16.
IntroiniA, BostromS, BradleyF, et al.: Seminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants. PLoS Pathog, 2017; 13:e1006402.
17.
MunchJ, RuckerE, StandkerL, et al.: Semen-derived amyloid fibrils drastically enhance HIV infection. Cell, 2007; 131:1059–1071.
18.
RoanNR, MullerJA, LiuH, et al.: Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe, 2011; 10:541–550.
